Respiratory tract microbiota has been described as the gatekeeper for respiratory health. We aimed to assess the impact of standard-of-care and experimental anti-tuberculosis treatment regimens on the respiratory microbiome and implications for treatment outcomes.
|Number of pages||10|
|Journal||The Lancet Microbe|
|Publication status||Published - 1 Nov 2023|